Open AccessInterferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: A project of the Kyushu University Liver Disease Study Group
Author(s) -
Norihiro Furusyo,
Masaki Katoh,
Yuji Tanabe,
Eiji Kajiwara,
Toshihiro Maruyama,
Junya Shimono,
Hironori Sakai,
Makoto Nakamuta,
Hideyuki Nomura,
Akihide Masumoto,
Shinji Shimoda,
Kazuhiro Takahashi,
Koichi Azuma,
Jun Hayashi
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i5.784
Subject(s) - ribavirin , medicine , discontinuation , gastroenterology , hepatitis c virus , alpha interferon , hepatitis c , genotype , interferon , interferon alfa , immunology , virus , biology , gene , biochemistry
To determine the efficacy of an interferon alpha and ribavirin combination treatment for Japanese patients infected with hepatitis C virus (HCV) of genotype 2, a multi-center study was retrospectively analyzed.